science

Tabelecleucel

Tabelecleucel is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Tabelecleucel rather than just read about it. In short: Tabelecleucel, sold under the brand name Ebvallo, is a medication used for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD). Tabelecleucel is an allogeneic, EBV-specific T-cell immunotherapy which targets and eliminates EBV-infected cells in a human leukocyte antigen (HLA)-restricted manner.

Key takeaways

Tabelecleucel belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Tabelecleucel to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Tabelecleucel from memory before moving on to harder problems.

Reference excerpt

Tabelecleucel, sold under the brand name Ebvallo, is a medication used for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD). Tabelecleucel is an allogeneic, EBV-specific T-cell immunotherapy which targets and eliminates EBV-infected cells in a human leukocyte antigen (HLA)-restricted manner. It is made of cells of the immune system called T-cells that have been taken from a donor (allogeneic) and are then mixed with EBV-infected B-cells from the same donor. The most common side effects include fever, diarrhea, fatigue, nausea (feeling sick), anemia (low red blood cell count), reduced appetite, hyponatremia (low sodium levels in the blood), abdominal pain, low white blood cell count, including neutrophils (white blood cells that fight infections), elevated blood levels of aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase (indicators of potential liver damage), constipation, hypoxia (low blood oxygen levels), dehydration, hypotension (low blood pressure), nasal congestion, and rash. Tabelecleucel was approved for medical use in the European Union in December 2022.

Medical uses Tabelecleucel is indicated as monotherapy for treatment of people aged two years of age and older with relapsed or refractory Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) who have received at least one prior therapy.

Post-transplant lymphoproliferative disorder

People who have undergone organ transplantation are routinely treated with immunosuppressive drugs to prevent transplant rejection. As a result of the treatment, some people develop Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (PTLD) in which white blood cells become infected with EBV and which in turn triggers excessive division of those cells. PTLD is initially non-cancerous, but can progress to cancerous Hodgkin lymphoma. First-line treatments of PTLD include monoclonal antibodies such as rituximab and chemotherapy if cancer has developed.

Adverse effects The most common side effects are fever, diarrhea, tiredness, feeling sick, low levels of red blood cells, decreased appetite and low blood sodium levels.

History The EMA recommendation is based on the results of an ongoing multicenter, phase III, single-arm, open-label clinical trial. The study investigated the efficacy and safety of tabelecleucel in 43 participants with relapsed/refractory EBV+ PTLD who had received at least one prior therapy.

Society and culture

Legal status On 13 October 2022, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization under exceptional circumstances for the medicinal product Ebvallo, intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD). As Ebvallo is an advanced therapy medicinal product, the CHMP positive opinion is based on an assessment by the Committee for Advanced Therapies. The applicant for this medicinal product is Atara Biotherapeutics Ireland Limited. Tabelecleucel was approved for medical use in the European Union in December 2022.

References

External links "Tabelecleucel". NCI Thesaurus. National Cancer Institute. Archived from the original on 22 October 2020.

Worked examples

Example 1 — a first encounter with Tabelecleucel

Start with the simplest possible case. Write down what Tabelecleucel claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Tabelecleucel before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Tabelecleucel ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Tabelecleucel

In research: Tabelecleucel appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Tabelecleucel in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Tabelecleucel is common in secondary-school and first-year university syllabi. It links to neighbouring topics Cancer treatments, Experimental antiviral drugs, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life: Look for Tabelecleucel outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Tabelecleucel in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Tabelecleucel means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Tabelecleucel out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Tabelecleucel in simple terms?

Why does Tabelecleucel matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Tabelecleucel?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Tabelecleucel.